APA (7th ed.) Citation

Bokemeyer, B., Plachta-Danielzik, S., Gilman, E., Giuseppe, R. d., Deppe, H., Mohl, W., . . . Schreiber, S. (2025). Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn's disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment. Journal of Crohn's & Colitis, 19(4), 1. https://doi.org/10.1093/ecco-jcc/jjaf051

Chicago Style (17th ed.) Citation

Bokemeyer, Bernd, et al. "Comparative Real-world Effectiveness of Ustekinumab Versus Anti-TNF in Crohn's Disease: 12-month Maintenance Phase Results from the Prospective, Observational RUN-CD Study Using Propensity Score Adjustment." Journal of Crohn's & Colitis 19, no. 4 (2025): 1. https://doi.org/10.1093/ecco-jcc/jjaf051.

MLA (9th ed.) Citation

Bokemeyer, Bernd, et al. "Comparative Real-world Effectiveness of Ustekinumab Versus Anti-TNF in Crohn's Disease: 12-month Maintenance Phase Results from the Prospective, Observational RUN-CD Study Using Propensity Score Adjustment." Journal of Crohn's & Colitis, vol. 19, no. 4, 2025, p. 1, https://doi.org/10.1093/ecco-jcc/jjaf051.